Yasmina Abdiche
SVP, Exploratory Research OmniAb, Inc.
Yasmina Abdiche, PhD is OmniAb’s Senior Vice President of Exploratory Research. Dr. Abdiche has more than 19 years of experience in protein engineering and biopharma industry experience focused on the application of analytical biosensor technologies and label-free interaction analysis in early-stage drug discovery. Dr. Abdiche joined the OmniAb team in September 2023 from FairJourney Biologics where she previously served as the Chief Technology Officer. Prior to that, Dr. Abdiche previously held senior management roles at biotechnology companies and contract research organizations including Carterra (where she co-founded the LSA biosensor platform), ImmunoPrecise Antibodies, ALX Oncology, and Revelar, after a 12-year career at Rinat, Pfizer’s biotherapeutic division. Dr. Abdiche received her PhD in Biological Chemistry and her master’s degree in Chemistry from the University of Oxford. Dr. Abdiche has authored more than 45 peer-reviewed publications and has had 25 patents granted in the therapeutic antibody space.
Seminars
- OmniUltra is an in vivo discovery platform designed to identify compact, target-selective peptide ligands with potential advantages for radioligand therapy and other applications.
- Peptides are generated and optimized in vivo, using natural selection mechanisms to enrich for high-affinity target engagement, specificity, favorable size, and tunable pharmacokinetic clearance.
- OmniUltra harnesses immune-system biology which may enable identification of drug-like binders earlier in discovery compared to traditional approaches.
